Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Kenner

Showing results (221-230 of 267) with videos related to

Pageof 27
Sort By:
Cell Death & Disease|October 14, 2016
Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Molecular Cancer|March 31, 2022
KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasisTanja Limberger, Michaela Schlederer, Karolina Trachtová, et al.
Oncogene|December 16, 2020
STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathwayAlexander Swoboda, Robert Soukup, Oliver Eckel, et al.
Molecular Cancer|January 4, 2022
Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsiesThomas Dillinger, Raheleh Sheibani-Tezerji, Walter Pulverer, et al.
Cell Death & Disease|July 25, 2018
Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Cell Death & Disease|August 14, 2019
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Gut|March 3, 2025
24-Nor-ursodeoxycholic acid improves intestinal inflammation by targeting T<sub>H</sub>17 pathogenicity and transdifferentiationCi Zhu, Nicole Boucheron, Osamah Al-Rubaye, et al.
Molecular Cancer|October 28, 2025
Safe delivery of a highly toxic anthracycline derivative through liposomal nanoformulation achieves complete cancer regressionAndrás Füredi, Szilárd Tóth, Kristóf Hegedüs, et al.
Nature Communications|November 30, 2019
The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN statusRicky M Trigg, Liam C Lee, Nina Prokoph, et al.
Communications Biology|May 24, 2020
IDO1<sup>+</sup> Paneth cells promote immune escape of colorectal cancerSandra Pflügler, Jasmin Svinka, Irene Scharf, et al.
Pageof 27

Showing results (221-230 of 267) with videos related to

Sort By:
Pageof 27
Cell Death & Disease|October 14, 2016
Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Molecular Cancer|March 31, 2022
KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasisTanja Limberger, Michaela Schlederer, Karolina Trachtová, et al.
Oncogene|December 16, 2020
STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathwayAlexander Swoboda, Robert Soukup, Oliver Eckel, et al.
Molecular Cancer|January 4, 2022
Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsiesThomas Dillinger, Raheleh Sheibani-Tezerji, Walter Pulverer, et al.
Cell Death & Disease|July 25, 2018
Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Cell Death & Disease|August 14, 2019
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Gut|March 3, 2025
24-Nor-ursodeoxycholic acid improves intestinal inflammation by targeting T<sub>H</sub>17 pathogenicity and transdifferentiationCi Zhu, Nicole Boucheron, Osamah Al-Rubaye, et al.
Molecular Cancer|October 28, 2025
Safe delivery of a highly toxic anthracycline derivative through liposomal nanoformulation achieves complete cancer regressionAndrás Füredi, Szilárd Tóth, Kristóf Hegedüs, et al.
Nature Communications|November 30, 2019
The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN statusRicky M Trigg, Liam C Lee, Nina Prokoph, et al.
Communications Biology|May 24, 2020
IDO1<sup>+</sup> Paneth cells promote immune escape of colorectal cancerSandra Pflügler, Jasmin Svinka, Irene Scharf, et al.
Pageof 27